...system combines world-class performance hardware, ...ftware, Agilents world-renowned support and column...lies--a combination that lets you reach uncompromi...sed on dependable data. The Agilent 6820 GC system...
7890A GC from Agilent Technologies
RF-5301 Fluorescence Spectrophotometer from Shimadzu
Kit for BASE20/50 dual control unit KIT50EHTD from Wave Biotech now part of GE Healthcare
Biology Products:(Date:11/24/2009)...YKJAVIK,Iceland,November24/PRNewswire-FirstCall/--...heapprovalofallofits,"firstday"motionsbytheU.S.Ban...cyCourt").deCODElastweekfiledavoluntarypetitionfor...dewiththe,BankruptcyCourt. , Theordersissuedb...rateitsbusinessduringtheChapter11proceedings.Inpar...
(Date:11/24/2009)...ANGHAI,Nov.24/PRNewswire-Asia/--ShanghaiBiolaxyann...SFDA)hasapprovedthe,investigationalnewdrugapplicat...tiveinsulinformulationtotreatdiabetes.ThisIND,appr...tudy. , Diabetesisadisordercharacteristicofhi...fdiabetesoftenresultinseveremicro-and,macro-vascul...
(Date:11/24/2009)...imaryefficacyendpointhasbeenmetforpatientswithadva...EBECCITY,Nov.24/PRNewswire-FirstCall/-AEternaZenta...albiopharmaceuticalcompanyfocusedonendocrinetherap...maPhase2studywithitstargetedcytotoxicpeptideconjug...dorrecurrentendometrialcancer.Inapersonalizedhealt...
(Date:11/24/2009)...NDIEGO,Nov.24,2009/PRNewswire-FirstCall/--ArenaPha...atthecompanyisscheduledtopresentatthePiperJaffray2...30a.m.EasternTime(8:30a.m.PacificTime)attheNewYork...t andChiefExecutiveOfficer,isscheduledtoprovideano...tanddiscoveryprograms. ,, Aliveaudiowebcastofth...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2